US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Alpha Cognition Inc.

0.3500

0.0000

Volume:- -

Turnover:- -

Market Cap:2.11M

PE:-0.89

High:0.3500

Open:0.3500

Low:0.3500

Close:0.3500

52wk High:0.3500

52wk Low:0.3500

Shares:6.03M

Float Shares:5.98M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3919

EPS(LYR):-0.1347

ROE:-2256.67%

ROA:-374.07%

PB:-1.52

PE(LYR):-2.60

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Alpha Cognition Inc.

Exchange:

OTCQB

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.alphacognition.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Alpha Cognition Inc., a clinical stage biopharmaceutical company, develops treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). It develops ALPHA-1062 for the treatment of mild-to-moderate Alzheimer's disease and mild traumatic brain injury; ALPHA-0602, a gene therapy for the treatment of ALS; and ALPHA-0702 and ALPHA-0802, a granulin epithelin motifs for the treatment of neurodegenerative diseases. The company was formerly known as Crystal Bridge Enterprises Inc. and changed its name to Alpha Cognition Inc. in March 2021. Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ACOGF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACOGF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACOGF\",,,,,undefined,":{"symbol":"ACOGF","market":"US","secType":"STK","nameCN":"Alpha Cognition Inc.","latestPrice":0.35,"timestamp":1770757200000,"preClose":0.35,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":5977591,"shares":6034200,"eps":-0.39186,"marketStatus":"Not Yet Opened","change":0,"latestTime":"02-10 16:00:00 EST Delay","open":0.35,"high":0.35,"low":0.35,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.39186,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770800400000},"marketStatusCode":0,"adr":0,"exchange":"OTCQB","adjPreClose":0.35,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACOGF\",,,,,undefined,":{"symbol":"ACOGF","floatShares":5977591,"roa":"-374.07%","roe":"-2256.67%","lyrEps":-0.134681,"shares":6034200,"dividePrice":0,"high":0.35,"amplitude":0,"preClose":0.35,"low":0.35,"week52Low":0.35,"pbRate":"-1.52","week52High":0.35,"institutionHeld":0,"latestPrice":0.35,"eps":-0.39186,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.39186,"open":0.35,"prevYearClose":0.35,"prevWeekClose":0.35,"prevMonthClose":0.35,"prevQuarterClose":0.35,"fiveDayClose":0.35,"twentyDayClose":0.35,"sixtyDayClose":0.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACOGF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-05","symbol":"ACOGF","defaultRemindTime":1730817000000,"type":"split","dateTimestamp":1730782800000,"forFactor":25,"toFactor":1,"ratio":25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACOGF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACOGF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1721365200000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.alphacognition.com","description":"Alpha Cognition Inc., a clinical stage biopharmaceutical company, develops treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). It develops ALPHA-1062 for the treatment of mild-to-moderate Alzheimer's disease and mild traumatic brain injury; ALPHA-0602, a gene therapy for the treatment of ALS; and ALPHA-0702 and ALPHA-0802, a granulin epithelin motifs for the treatment of neurodegenerative diseases. The company was formerly known as Crystal Bridge Enterprises Inc. and changed its name to Alpha Cognition Inc. in March 2021. Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada.","exchange":"OTCQB","name":"Alpha Cognition Inc.","nameEN":"Alpha Cognition Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ACOGF\",market:\"US\",,,undefined,":null}}